STOCK TITAN

Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Neurocrine Biosciences (Nasdaq: NBIX) will announce its third quarter 2021 financial results on November 1, 2021, after market close. The company will then host a conference call and webcast at 1:30 p.m. PT to discuss the results and provide updates. Participants can join via phone or through their website. Neurocrine specializes in treatments for neurological and endocrine disorders, with a diverse product portfolio.

Positive
  • None.
Negative
  • None.

SAN DIEGO, Oct. 11, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it will report third quarter 2021 financial results after the Nasdaq market closes on Monday, November 1, 2021. Neurocrine will then host a conference call and webcast to discuss its financial results and provide a company update that day at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

Participants can access the live conference call by dialing 800-895-3361 (US) or 785-424-1062 (International) using the conference ID: NBIX. The webcast can also be accessed on Neurocrine's website under Investors at www.neurocrine.com. A replay of the webcast will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn(*in collaboration with AbbVie)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-third-quarter-2021-financial-results-301397165.html

SOURCE Neurocrine Biosciences, Inc.

FAQ

When will Neurocrine Biosciences announce its third quarter 2021 financial results?

Neurocrine Biosciences will announce its third quarter 2021 financial results on November 1, 2021.

What time is the Neurocrine Biosciences conference call for the third quarter results?

The conference call will take place at 1:30 p.m. Pacific Time on November 1, 2021.

How can I access the Neurocrine Biosciences Q3 financial results call?

You can access the call by dialing 800-895-3361 (US) or 785-424-1062 (International) using conference ID: NBIX.

Will there be a replay of the Neurocrine Biosciences conference call?

Yes, a replay will be available on Neurocrine's website approximately one hour after the event.

What is Neurocrine Biosciences known for?

Neurocrine Biosciences is known for its treatments targeting neurological and endocrine disorders, including FDA-approved therapies.

Neurocrine Biosciences Inc

NASDAQ:NBIX

NBIX Rankings

NBIX Latest News

NBIX Stock Data

13.82B
99.72M
1%
96.03%
4.19%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States of America
SAN DIEGO